Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Japan
Biotech
Eisai pays $46M for Japan rights to Newron's schizophrenia med
Newron has secured 44 million euros in upfront cash from an Eisai subsidiary for select Asia rights to its add-on schizophrenia treatment.
James Waldron
Dec 13, 2024 8:37am
GE HealthCare to take over Japanese radiopharmaceutical venture
Dec 2, 2024 2:00pm
Astellas telegraphs new cell therapy site in Japan, 24 US layoffs
Oct 9, 2024 5:45pm
Fujitsu partners with Paradigm to boost clinical trials in Japan
Aug 28, 2024 12:43pm
Medtronic nets Japan approval for pulsed field ablation system
May 13, 2024 11:25am
AstraZeneca's heart disease trial hits, teeing up Pfizer clash
Feb 2, 2024 6:43am
